Substance P blockade effects on bone marrow hematopoiesis in secondary chronic inflammation
DOI:
https://doi.org/10.12775/JEHS.2020.10.02.040Keywords
red bone marrow, rats, experiment, inflammation, substance PAbstract
Inflammation is defined by the features of bone marrow hematopoiesis. Thus, an objective of the study was to determine the substance P inhibition effects on bone marrow hematopoiesis in secondary chronic carrageenan-induced inflammation in experimental prospective controlled study on 132 white male WAG rats. On the background of blockade of substance P, the course of inflammation was characterized by a less intense neutrophilic reaction and the development of the lymphocyte component at earlier stages of inflammation. Given the peculiarities of bone marrow hematopoiesis in carrageenan secondary chronic inflammation on the background of its suppression, the influence of substance P on the course of chronic inflammation is certain.
References
Navratilova E. Substance P and Inflammatory Pain: Getting It Wrong and Right Simultaneously / E. Navratilova, F. Porreca // Neuron. — 2019. — Vol. 101, No. 3. — P. 353–355. — doi: 10.1016/j.neuron.2019.01.034.
Tachykinins and tachykinin receptors: a growing family / J. N. Pennefather, A. Lecci, M. L. Candenas [et al.] // Life Sci. — 2004. — Vol. 74, No. 12. — P. 1445–1663.
Substance P and neurotensin in the limbic system: Their roles in reinforcement and memory consolidation / L. Lénárd, K. László, E. Kertes [et al.] // Neurosci. Biobehav. Rev. — 2018. — Vol. 85. — P. 1-20— doi: 10.1016/j.neubiorev.2017.09.003.
Suvas S. Role of substance P neuropeptide in inflammation, wound healing, and tissue homeostasis // J. Immunol. — 2017. — Vol. 199, No. 5. — P. 1543–1552.
Euler U. S. An unidentified depressor substance in certain tissue extracts / U.S. Euler, J.H Gaddum // J. Physiol. — 1931. — Vol. 72. — P. 74–87.
Majkowska-Pilip A. The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy / A. Majkowska-Pilip, P. K. Halik, E. Gniazdowska // Pharmaceutics. — 2019. — Vol. 11, No. 9. — pii: E443 — doi: 10.3390/pharmaceutics11090443.
Cough hypersensitivity in patients with obstructive sleep apnea hypopnea syndrome / C. Shi, S. Liang, X. Xu [et al.] // Sleep Breath. — 2018. — doi: 10.1007/s11325-018-1641-7.
Reciprocal regulation of substance P and IL-12/IL-23 and the associated cytokines, IFNγ/IL-17: a perspective on the relevance of this interaction to multiple sclerosis / J. Vilisaar, K. Kawabe, M. Braitch [et al.] // J. Neuroimmune Pharmacol. — 2015. —Vol. 10, No. 3. — P. 457–467.
TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization / O. Gouin, L. L’Herondelle, N. Lebonva [et al.] // Prot. Cell. — 2017. — Vol. 8, No. 9. — P. 644–661.
Klymenko N. A. Role of inflammation in pathology // General pathology and pathologic physiology. — 2010. — Vol. 5, No. 2. — P. 20–21.
Klymenko N. A. Substantiation of the model of chronic (secondary) inflammation / N. A. Klymenko, S. V. Tatarko, A. N. Shevchenko [et al.] // Experimental and Clinical Medicine. — 2007. — No. 2. — P. 12–17.
An FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orally / R. Lim, J. M. Morrill, S. G. Prushik [et al.] // J. Gastrointest. Surg. — 2008. — Vol. 12. — P. 1754–1761. — doi: 10.1007/s11605-008-0634-4.
Klymenko N. A. Hematologic mechanisms of inflammation chronization / N. A. Klymenko, A. N. Shevchenko. — Kharkiv, 2010. — 88 p.
Stead R. H. Neuropeptide regulation of mucosal immunity / R. H. Stead, J. Bienenstock, A. M. Stanisz // Immunol. Rev. — 1987. — Vol. 100. — P. 333–359. doi: 10.1111/j.1600-065x.1987.tb00538.x
Noradrenergic and peptidergic innervation of lymphoid organs / S. Y. Felten, D. L. Felten, D. L. Bellinger, J. A. Olschowka // Chem. Immunol. — 1992. — Vol. 52. — P. 25–48.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons non-exclusive license (CC BY-ND 4.0).Stats
Number of views and downloads: 28
Number of citations: 0
